PRO MEDICUS LIMITED — Director's Dealing 2018

Mar 19, 2018

Appendix 3Y Change of Director’s Interest Notice

Listing Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Pro Medicus Limited ABN 25 006 194 752

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Anthony Barry HALL
Date of last notice	27 August 2015

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest	Ordinary fully paid shares in Pro Medicus
(including registered holder)Note: Provide details of the circumstances giving rise to the relevant	Limited held by Anthony Barry HALL
interest.
Date of change	14 March 2018
	15 March 2018
	16 March 2018
	19March 2018
No. of securities held prior to change	30,067,500 ordinary shares consisting off:-
	29,200,000 ordinary shares held
	under Anthony Barry HALL
	867,500 ordinary shares held under
	Akay Superannuation Fund
Class	Ordinary shares
Number acquired	Nil
Number disposed	14 March 2018 – 31,500 ordinary shares
	15 March 2018 – 5,000 ordinary shares
	16 March 2018 – 13,500 ordinary shares
	19 March 2018 – 950,000 ordinary shares

• See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/ConsiderationNote: If consideration is non-cash, provide details and estimated valuation	14 March 2018 – $8.5193 per share15 March 2018 – $8.4872 per share16 March 2018 – $8.4411 per share19 March 2018 – $8.00per share
No. of securities held after change	29,067,500 ordinary shares consisting off:-28,200,000 ordinary shares heldunder Anthony Barry HALL867,500 ordinary shares held underAkay Superannuation Fund
Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back	On market trade – 14, 15 & 16 March 2018Off market trade – 19 March 2018

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

	Detail of contract	Detail of contract	Detail of contract	N/A	N/A	N/A	N/A	N/A
	Nature of interest			N/A
	Name of registered holder(if issued securities)			N/A
	Date of change			N/A
	No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract in relation			N/A
	to which th	e interest has changed
	Intere	st acquired		N/A
	Intere	st disposed		N/A
	Value/	Consideratio	n	N/A
Note: If coestimatedIntere	Note: If coestimated	nsideration is non-casvaluation	, provide details and an
	Intere	st after chang	e	N/A
S h
		1 f dfid

• See chapter 19 for defined terms.

Appendix 3Y Page 2

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed	No
above traded during a+closed period where prior written
clearance was required?
If so, was prior written clearance provided to allow the	N/A
trade to proceed during this period?
If prior written clearance was provided, on what date was	N/A
this provided?

For and on behalf of Pro Medicus Limited

==> picture [133 x 63] intentionally omitted <==

Clayton Hatch Company Secretary 20 March 2018

• See chapter 19 for defined terms.

Appendix 3Y Page 3